COVID-19 Delta and other variants, some questions of interest

Authors

Keywords:

coronavirus infections

Downloads

Download data is not yet available.

Author Biographies

Luis Monteagudo Lima, Hospital Provincial Clínico Quirúrgico Universitario "Arnaldo Milián Castro"

Especialista en I Grado en Medicina Interna. Especialista en II Grado en Cardiología. Máster en Urgencia al Grabe. Profesor Auxiliar en la Universidad de Ciencias Médicas de Villa Clara.

Gerardo Álvarez Álvarez, Universidad de Ciencias Médicas de Villa Clara

Doctor en Ciencias Médicas. Máster en Psicología Médica. Especialista de I y II Grado en Medicina Interna. Profesor Consultante y Titular, Investigador Auxiliar, Universidad de Ciencias Médicas de Villa Clara.

References

1.Ríos Gordillo CA. El virus, el síntoma y el gran pánico. Reflexiones sobre un estado social. SOMEPSO [Internet]. 2021 [citado 02/08/2021];6(1):99-115. Disponible en: https://revistasomepso.org/index.php/revistasomepso/article/view/100

2.Zavaro Pérez C. Reflexiones sobre un virus con Corona. Herreriana [Internet]. 2021 [citado 02/08/2021];3(1):6-11. Disponible en: https://repository.uaeh.edu.mx/revistas/index.php/herreriana/article/view/6967. https://doi.org/10.29057/h.v3i1.6967

3.King AMQ, Adams MJ, Carstens EB, Lefkowitz EJ. Virus taxonomy. Ninth Report of the International Committee on Taxonomy of Viruses [Internet] Amsterdam: Elsevier; 2011 [citado 02/08/2021]. Disponible en: https://www.sciencedirect.com/book/9780123846846/virus-taxonomy

4.Maroto Vela MC. SARS-CoV-2: problemas e incertidumbres. An RANM [Internet]. 2020 [citado 02/08/2021];137(2):98-103. Disponible en: https://analesranm.es/revista/2020/137_02/13702_rev01. https://dx.doi.org/10.32440/ar.2020.137.02.rev01

5.Maroto Vela MC, Piédrola Angulo G. Los coronavirus. An RANM [Internet]. 2019 [citado 02/08/2021];136(3):235-238. Disponible en: https://analesranm.es/revista/2019/136_03/13603rev01. https://dx.doi.org/10.32440/ar.2019.136.03.rev01

6.Kai H, Kai M. Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors—lessons from available evidence and insights into COVID-19. Hypertens Res [Internet]. 2020 [citado 02/08/2021];43:648-654. Disponible en: https://www.nature.com/articles/s41440-020-0455-8. https://doi.org/10.1038/s41440-020-0455-8

7.Sandoval W. COVID-19. Metro Ciencia [Internet]. 2021 [citado 02/08/2021];29(2):3-6. Disponible en: https://revistametrociencia.com.ec/index.php/revista/article/view/166. https://doi.org/10.47464/MetroCiencia/vol29/2/2021/3-6

8.World Health Organization. Tracking SARS-CoV-2 variants [Internet]. Ginebra: WHO; 2021 [citado 02/08/2021]. Disponible en: https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/

9.Pérez-Abeledo M, Sanz Moreno JC. Variantes de SARS-CoV-2, una historia todavía inacabada. Vacunas [Internet]. 2021 [citado 02/08/2021];22(3):173–179. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275477/. https://dx.doi.org/10.1016/j.vacun.2021.06.003

10.McCarthy KR, Rennick LJ, Nambulli S, Robinson-McCarthy LR, Bain WG, Haidar G, et al. Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape. Science [Internet]. 2021 [citado 02/08/2021];371(6534):1139-42. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7971772/. https://dx.doi.org/10.1126/science.abf6950

11.Saavedra Trujillo CH. Antecedentes de infección por SARS-CoV-2/Covid19. Infectio [Internet]. 2021 [citado 02/08/2021];25(4)(Suppl 1):2-9. Disponible en: https://www.revistainfectio.org/index.php/infectio/article/view/971/1113

12.Burki T. Understanding variants of SARS-CoV-2. Lancet [Internet]. 2021 [citado 26/06/2021];397(10273):462. Disponible en: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00298-1/fulltext. https://doi.org/10.1016/S0140-6736(21)00298-1

13.López Mora E, Espinoza Rojas J, Dabanch Peña J, Cruz Choappa R. Emergencia de variante Delta-B.1.617.2. Su impacto potencial en la evolución de la pandemia por SARS-CoV-2. Bol Micol [Internet]. 2021 [citado 26/06/2021];36(1):12-16. Disponible en: https://revistas.uv.cl/index.php/Bolmicol/article/view/2883. https://doi.org/10.22370/bolmicol.2021.36.1.2883

14.Ortiz de Lejarazu y Leonardo R. Futuro de la vacunación frente a la infección por SARS-CoV-2. Open Respir Arch [Internet]. 2021 [citado 26/06/2021];3(2021):100117. Disponible en: https://www.elsevier.es/en-revista-open-respiratory-archives-11-avance-resumen-futuro-vacunacion-frente-infeccion-por-S2659663621000369. https://doi.org/10.1016/j.opresp.2021.100117

15.Mascola JR, Graham BS, Fauci AS. SARS-CoV-2 Viral Variants—Tackling a moving target. JAMA [Internet]. 2021 [citado 26/06/2021];325(13):1261-2. Disponible en: https://jamanetwork.com/journals/jama/fullarticle/2776542. https://doi.org/10.1001/jama.2021.2088

16.Kantor IN, Lüthy IA, Ritacco V. Las variantes del SARS-CoV-2 y la llamada resistencia a las vacunas. Medicina (Buenos Aires) [Internet] 2021 [citado 26/06/2021];81(3):421-426. Disponible en: https://www.medicinabuenosaires.com/revistas/vol81-21/n3/421.pdf

17.Lauring AS, Hodcroft EB. Genetic Variants of SARS-CoV-2—What Do They Mean? JAMA [Internet]. 2021 [citado 26/06/2021];325(6):529-531. Disponible en: https://jamanetwork.com/journals/jama/fullarticle/2775006. https://doi.org/10.1001/jama.2020.27124

18.González RR. Variante delta, el gran desafío. Vanguardia [Internet]. 17/08/2021 [citado 29/08/2021]. Disponible en: http://www.vanguardia.cu/villa-clara/20660-variante-delta-el-gran-desafio

Downloads

Published

2021-10-28

How to Cite

1.
Monteagudo Lima L, Álvarez Álvarez G. COVID-19 Delta and other variants, some questions of interest. Acta Méd Centro [Internet]. 2021 Oct. 28 [cited 2025 Jun. 27];15(4):627-31. Available from: https://revactamedicacentro.sld.cu/index.php/amc/article/view/1566

Issue

Vol. 15 No. 4 (2021): October-December

Section

Letters to the Editor

License

Authors who have publications with this journal agree to the following terms:

  1. Authors will retain their copyright and assign to the journal the right of first publication of their work, which will simultaneously be subject to a Creative Commons License / Attribution-Noncommercial 4.0 International (CC BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
  2. Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional repository or publishing it in a monographic volume) as long as the initial publication in this journal is indicated.
  3. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).